Clinique de l'Europe in Rouen delivers comprehensive bariatric surgery services featuring gastric sleeve, gastric bypass, and lap-band procedures addressing obesity and metabolic disease throughout France. Operating as part of the Vivalto Santé network, the facility combines advanced surgical capability with full-service patient support.
The bariatric surgery program emphasizes comprehensive obesity management incorporating surgical intervention with lifestyle modification and ongoing support. Preoperative assessment includes thorough medical evaluation, nutritional analysis, and psychological screening ensuring appropriate surgical candidacy. The integrated approach maximizes both operative success and sustainable long-term outcomes.
Gastric sleeve gastrectomy serves as the primary surgical intervention, utilizing minimally invasive laparoscopic techniques. The procedure produces durable weight loss through gastric volume restriction while maintaining normal digestive anatomy. Most patients achieve 50-70% excess weight loss with sustained improvement in obesity-related conditions.
Gastric bypass provides alternative bariatric surgery combining gastric restriction with partial intestinal bypass for enhanced metabolic effect. The minimally invasive approach enables rapid recovery while delivering significant weight loss and marked metabolic improvement including diabetes reversal.
Lap-band adjustable gastric banding offers reversible restrictive surgery with adjustment capability throughout recovery. The laparoscopic placement enables quick recovery while producing gradual, sustainable weight loss. Port-based adjustments allow personalized restriction optimization.
The clinic provides comprehensive postoperative care including medical monitoring, nutritional guidance, and psychiatric support ensuring sustained outcomes. Patients benefit from structured educational programs, support groups, and follow-up protocols monitoring progress and addressing concerns. The facility maintains advanced surgical capability and commitment to evidence-based obesity treatment.
